Frontiers | Beyond Psilocybin: Exploring the Clinical Potential of Alternative and Novel Psychedelics

Beyond Psilocybin: Exploring the Clinical Potential of Alternative and Novel Psychedelics

5,566
Total downloads
34k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 18 Apr 2024

Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress

Julia Ruixi Wang
Samuel J. Mendez Araque
Gina Micciche
Andrew McMillan
Emily Coughlin
Rosalie Mattiola
Diana English
Kristopher Kaliebe

doi 10.3389/fpsyt.2024.1301960

1,932 views

ORIGINAL RESEARCH

Published on 11 Jan 2024

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial

Ellen James
David Erritzoe
Tiffanie Benway
Zelah Joel
Christopher Timmermann
Meghan Good
Claudio Agnorelli
Brandon M. Weiss
Tommaso Barba
5 more
Carol Routledge

doi 10.3389/fpsyt.2023.1305796

3,107 views
2 citations

ORIGINAL RESEARCH

Published on 08 Jan 2024

In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin

Nathan T. Jones
Laura Wagner
Molly C. Pellitteri Hahn
Cameron O. Scarlett
Cody J. Wenthur

doi 10.3389/fpsyt.2023.1303365

4,904 views
3 citations

ORIGINAL RESEARCH

Published on 08 Jan 2024

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects

Helena D. Aicher
Michael J. Mueller
Dario A. Dornbierer
Dila Suay
Claudius Elsner
Ilhui Wicki
Daniel Meling
Luzia Caflisch
Alexandra Hempe
4 more
Milan Scheidegger

doi 10.3389/fpsyt.2023.1302559

5,974 views
5 citations

CASE REPORT

Published on 23 Nov 2023

5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study

Anya Ragnhildstveit
Ryan Khan
Paul Seli
Lisa Claire Bass
River Jude August
Miriam Kaiyo
Nathaniel Barr
Laura Kate Jackson
Michael Santo Gaffrey
1 more
Lynnette Astrid Averill

doi 10.3389/fpsyt.2023.1271152

14,840 views
4 citations

PERSPECTIVE

Published on 21 Nov 2023

Biological studies of clavine alkaloids targeting CNS receptors

Nikhil R. Tasker
Ethan J. Pazur
Peter Wipf

doi 10.3389/fpsyt.2023.1286941

1,778 views
3 citations

CASE REPORT

Published on 25 Oct 2023

Case report: Maintaining altered states of consciousness over repeated ketamine infusions may be key to facilitate long-lasting antidepressant effects: some initial lessons from a personalized-dosing single-case study

Steffen Reissmann
Matthias Hartmann
Andreas Kist
Matthias E. Liechti
Kurt Stocker

doi 10.3389/fpsyt.2023.1197697

2,168 views

Share on

Frontiers in Psychiatry

Psychopharmacology

Impact

34kTopic views
26kArticle views
5,566Article downloads

View impact

Submit your idea

Articles

Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial

In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects

5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study

Biological studies of clavine alkaloids targeting CNS receptors

Case report: Maintaining altered states of consciousness over repeated ketamine infusions may be key to facilitate long-lasting antidepressant effects: some initial lessons from a personalized-dosing single-case study

Frontiers in Psychiatry

Impact